The value of comparative efficacy studies in informing rheumatology guidelines

Nature Reviews Rheumatology, Published online: 21 September 2022; doi:10.1038/s41584-022-00846-9New research reinforces the fact that most recommendations in rheumatology are not informed by comparative efficacy randomized controlled trials. Performing these studies is time and resource intensive. Policies and funding to perform these studies in a timely and resource constraint manner are essential.

Source: Nature Reviews Rheumatology - September 21, 2022 Category: Rheumatology Authors: Raveendhara R. Bannuru Source Type: research